Aspen Aerogels (NYSE:ASPN) Given New $29.00 Price Target at Piper Sandler

Aspen Aerogels (NYSE:ASPN) had its price target raised by Piper Sandler from $20.00 to $29.00 in a research note released on Friday, Benzinga reports. They currently have an overweight rating on the construction company’s stock.

Several other analysts have also recently commented on ASPN. TheStreet upgraded shares of Aspen Aerogels from a d+ rating to a c- rating in a research note on Wednesday, March 6th. HC Wainwright boosted their target price on Aspen Aerogels from $20.00 to $25.00 and gave the stock a buy rating in a research report on Friday. Finally, Roth Mkm reissued a buy rating and issued a $22.00 price target on shares of Aspen Aerogels in a report on Tuesday, April 30th. One equities research analyst has rated the stock with a sell rating and six have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of Moderate Buy and an average price target of $25.17.

Aspen Aerogels Price Performance

Shares of NYSE:ASPN opened at $25.90 on Friday. The company has a debt-to-equity ratio of 0.24, a current ratio of 4.01 and a quick ratio of 3.29. Aspen Aerogels has a 12 month low of $5.32 and a 12 month high of $25.91. The firm has a market capitalization of $1.97 billion, a P/E ratio of -58.86 and a beta of 1.97. The company’s fifty day moving average price is $16.90 and its 200 day moving average price is $13.90.

Aspen Aerogels (NYSE:ASPN) last posted its earnings results on Tuesday, February 13th. The construction company reported ($0.01) EPS for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.11. The business had revenue of $84.22 million for the quarter, compared to analysts’ expectations of $83.82 million. Aspen Aerogels had a negative return on equity of 6.35% and a negative net margin of 10.73%. During the same quarter in the previous year, the firm earned ($0.20) earnings per share. As a group, sell-side analysts predict that Aspen Aerogels will post 0.03 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Aspen Aerogels

A number of large investors have recently made changes to their positions in the business. Banque Cantonale Vaudoise grew its stake in Aspen Aerogels by 37.5% in the first quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock valued at $81,000 after purchasing an additional 1,252 shares in the last quarter. McAdam LLC purchased a new stake in shares of Aspen Aerogels during the 4th quarter worth about $191,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of Aspen Aerogels by 38.5% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,971 shares of the construction company’s stock valued at $205,000 after buying an additional 3,607 shares during the last quarter. Cornerstone Investment Partners LLC bought a new stake in shares of Aspen Aerogels in the 4th quarter valued at approximately $230,000. Finally, Raymond James Financial Services Advisors Inc. acquired a new position in Aspen Aerogels in the fourth quarter worth approximately $265,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.